266 related articles for article (PubMed ID: 31102503)
1. MiR-320a induces diabetic nephropathy via inhibiting MafB.
He M; Wang J; Yin Z; Zhao Y; Hou H; Fan J; Li H; Wen Z; Tang J; Wang Y; Wang DW; Chen C
Aging (Albany NY); 2019 May; 11(10):3055-3079. PubMed ID: 31102503
[TBL] [Abstract][Full Text] [Related]
2. Overexpression of Mafb in podocytes protects against diabetic nephropathy.
Morito N; Yoh K; Ojima M; Okamura M; Nakamura M; Hamada M; Shimohata H; Moriguchi T; Yamagata K; Takahashi S
J Am Soc Nephrol; 2014 Nov; 25(11):2546-57. PubMed ID: 24722438
[TBL] [Abstract][Full Text] [Related]
3. miR-188-3p abolishes germacrone-mediated podocyte protection in a mouse model of diabetic nephropathy in type I diabetes through triggering mitochondrial injury.
Wang Y; Feng F; He W; Sun L; He Q; Jin J
Bioengineered; 2022 Jan; 13(1):774-788. PubMed ID: 34847832
[TBL] [Abstract][Full Text] [Related]
4. Suppressed ER-associated degradation by intraglomerular cross talk between mesangial cells and podocytes causes podocyte injury in diabetic kidney disease.
Fujimoto D; Kuwabara T; Hata Y; Umemoto S; Kanki T; Nishiguchi Y; Mizumoto T; Hayata M; Kakizoe Y; Izumi Y; Takahashi S; Mukoyama M
FASEB J; 2020 Nov; 34(11):15577-15590. PubMed ID: 32996639
[TBL] [Abstract][Full Text] [Related]
5. LncRNA MALAT1/microRNA let-7f/KLF5 axis regulates podocyte injury in diabetic nephropathy.
Zhang H; Yan Y; Hu Q; Zhang X
Life Sci; 2021 Feb; 266():118794. PubMed ID: 33232688
[TBL] [Abstract][Full Text] [Related]
6.
Liu X; Jiang L; Zeng H; Gao L; Guo S; Chen C; Liu X; Zhang M; Ma L; Li Y; Qi X; Wu Y
Autophagy; 2024 May; 20(5):1072-1097. PubMed ID: 38050963
[TBL] [Abstract][Full Text] [Related]
7. Triptolide inhibits oxidative stress and inflammation via the microRNA-155-5p/brain-derived neurotrophic factor to reduce podocyte injury in mice with diabetic nephropathy.
Gao J; Liang Z; Zhao F; Liu X; Ma N
Bioengineered; 2022 May; 13(5):12275-12288. PubMed ID: 35603354
[TBL] [Abstract][Full Text] [Related]
8. Dysregulation of low-density lipoprotein receptor contributes to podocyte injuries in diabetic nephropathy.
Zhang Y; Ma KL; Liu J; Wu Y; Hu ZB; Liu L; Liu BC
Am J Physiol Endocrinol Metab; 2015 Jun; 308(12):E1140-8. PubMed ID: 25921580
[TBL] [Abstract][Full Text] [Related]
9. MicroRNA-503 contributes to podocyte injury via targeting E2F3 in diabetic nephropathy.
Zha F; Bai L; Tang B; Li J; Wang Y; Zheng P; Ji T; Bai S
J Cell Biochem; 2019 Aug; 120(8):12574-12581. PubMed ID: 30834596
[TBL] [Abstract][Full Text] [Related]
10. Long noncoding RNA SNHG5 promotes podocyte injury via the microRNA-26a-5p/TRPC6 pathway in diabetic nephropathy.
Zhou Y; Li ZL; Ding L; Zhang XJ; Liu NC; Liu SS; Wang YF; Ma RX
J Biol Chem; 2022 Dec; 298(12):102605. PubMed ID: 36257404
[TBL] [Abstract][Full Text] [Related]
11. Exosome secreted from adipose-derived stem cells attenuates diabetic nephropathy by promoting autophagy flux and inhibiting apoptosis in podocyte.
Jin J; Shi Y; Gong J; Zhao L; Li Y; He Q; Huang H
Stem Cell Res Ther; 2019 Mar; 10(1):95. PubMed ID: 30876481
[TBL] [Abstract][Full Text] [Related]
12. MicroRNA-770-5p is involved in the development of diabetic nephropathy through regulating podocyte apoptosis by targeting TP53 regulated inhibitor of apoptosis 1.
Zhang SZ; Qiu XJ; Dong SS; Zhou LN; Zhu Y; Wang MD; Jin LW
Eur Rev Med Pharmacol Sci; 2019 Feb; 23(3):1248-1256. PubMed ID: 30779094
[TBL] [Abstract][Full Text] [Related]
13. MicroRNA-29c is a signature microRNA under high glucose conditions that targets Sprouty homolog 1, and its in vivo knockdown prevents progression of diabetic nephropathy.
Long J; Wang Y; Wang W; Chang BH; Danesh FR
J Biol Chem; 2011 Apr; 286(13):11837-48. PubMed ID: 21310958
[TBL] [Abstract][Full Text] [Related]
14. MiRNA-337 leads to podocyte injury in mice with diabetic nephropathy.
Zhao SM; Zhang T; Qiu Q; Xu C; Ma LJ; Liu J; Wang Z; Li YC; Huang J; Zhang M
Eur Rev Med Pharmacol Sci; 2019 Oct; 23(19):8485-8492. PubMed ID: 31646579
[TBL] [Abstract][Full Text] [Related]
15. [MiR-34a alleviates podocyte injury in mice with diabetic nephropathy by targeted downregulation of Notch signaling pathway].
Wang H; Liu H; Zhang Y; Chen W
Nan Fang Yi Ke Da Xue Xue Bao; 2022 Dec; 42(12):1839-1845. PubMed ID: 36651252
[TBL] [Abstract][Full Text] [Related]
16. Impaired Podocyte Autophagy Exacerbates Proteinuria in Diabetic Nephropathy.
Tagawa A; Yasuda M; Kume S; Yamahara K; Nakazawa J; Chin-Kanasaki M; Araki H; Araki S; Koya D; Asanuma K; Kim EH; Haneda M; Kajiwara N; Hayashi K; Ohashi H; Ugi S; Maegawa H; Uzu T
Diabetes; 2016 Mar; 65(3):755-67. PubMed ID: 26384385
[TBL] [Abstract][Full Text] [Related]
17. Metadherin facilitates podocyte apoptosis in diabetic nephropathy.
Liu WT; Peng FF; Li HY; Chen XW; Gong WQ; Chen WJ; Chen YH; Li PL; Li ST; Xu ZZ; Long HB
Cell Death Dis; 2016 Nov; 7(11):e2477. PubMed ID: 27882943
[TBL] [Abstract][Full Text] [Related]
18. Downregulation of miR-17 suppresses TGF-β1-mediated renal fibrosis through targeting Smad7.
Fu H; Chu D; Geng X
Mol Cell Biochem; 2021 Aug; 476(8):3051-3064. PubMed ID: 33797702
[TBL] [Abstract][Full Text] [Related]
19. miR-1187 induces podocyte injury and diabetic nephropathy through autophagy.
Chen B; He Q
Diab Vasc Dis Res; 2023; 20(3):14791641231172139. PubMed ID: 37208852
[TBL] [Abstract][Full Text] [Related]
20. MiR-874 alleviates renal injury and inflammatory response in diabetic nephropathy through targeting toll-like receptor-4.
Yao T; Zha D; Gao P; Shui H; Wu X
J Cell Physiol; 2018 Jan; 234(1):871-879. PubMed ID: 30171701
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
